Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck

K. J. Harrington, C. Lewanski, A. D. Northcote, J. Whittaker, A. M. Peters, R. G. Vile, J. S.W. Stewart

Research output: Contribution to journal › Article › peer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck'. Together they form a unique fingerprint.

Medicine & Life Sciences